This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Alicia Hawes: Innovator in Genomic Sequencing Technologies
Introduction
Alicia Hawes is a prominent inventor based in Tarrytown, NY (US). She has made significant contributions to the field of genomic sequencing, particularly in developing systems and methods that enhance the accuracy of genotype identification for high repeat genes. Her innovative work is crucial for advancing genetic research and applications.
Latest Patents
Alicia holds a patent for "Systems and methods for correcting for noise and systemic variations in sequencing data." This patent focuses on providing accurate genotypes by identifying repeat structures in sequencing reads. The process involves removing abnormal repeat structures, filtering out sequences with structural artifacts, and generating datasets that categorize sequencing reads by allele. Ultimately, her method leads to the determination of protein-altering variant status based on amino-acid sequences.
Career Highlights
Alicia is currently employed at Regeneron Pharmaceuticals, Inc., where she continues to push the boundaries of genomic research. Her work has been instrumental in developing technologies that improve the reliability of sequencing data, which is vital for various applications in medicine and biotechnology.
Collaborations
Alicia collaborates with notable colleagues, including Lei Chen and Charles Paulding. These partnerships enhance her research efforts and contribute to the innovative environment at Regeneron Pharmaceuticals.
Conclusion
Alicia Hawes is a trailblazer in the field of genomic sequencing, with her patent and work at Regeneron Pharmaceuticals showcasing her commitment to advancing genetic research. Her contributions are paving the way for more accurate and reliable genetic analysis in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
